In a case—control study of bladder cancer-associated biomarkers, voided urine samples from 127 subjects, 64 with bladder cancer patients and 63 controls, were examined, and the urine concentrations of four different biomarkers, including the CD44 protein, were assessed via ELISA [94]. The gene discussed is CD44; the disease is urinary bladder carcinoma.